Effect of platelet concentrate on union of long-bone delayed union versus no treatment control .
Role of isolated percutaneous autologous platelet concentrate in delayed union of long bones
Eur J Orthop Surg Traumatol. 2018 Jul;28(5):985-990. doi: 10.1007/s00590-017-2077-740 patients with a delayed union of a long bone fracture were randomized to either receive or not receive autologous platelet concentrate application at the site of the fracture. The purpose of this study was to determine if there was a significant difference in the rate of progression to union within 36 weeks of injury between groups. Results demonstrated no significant difference in the rate of progression to union within 36 weeks of injury between the APC and control groups, nor a significant difference in mean time to union among those which did progress.
Unlock the Full ACE Report
You have access to 4 more FREE articles this month.
Click below to unlock and view this ACE Reports
Unlock Now
Critical appraisals of the latest, high-impact randomized controlled trials and systematic reviews in orthopaedics
Access to OrthoEvidence podcast content, including collaborations with the Journal of Bone and Joint Surgery, interviews with internationally recognized surgeons, and roundtable discussions on orthopaedic news and topics
Subscription to The Pulse, a twice-weekly evidence-based newsletter designed to help you make better clinical decisions
Exclusive access to original content articles, including in-house systematic reviews, and articles on health research methods and hot orthopaedic topics
Or upgrade today and gain access to all OrthoEvidencecontent for as little as $1.99 per week.
Already have an account? Log in
0 of 4 monthly FREE articles unlocked
